中文版 | English
Title

Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer

Author
Corresponding AuthorJin‑Tang Dong
Joint first authorQingqing Huang; Mingcheng Liu
Publication Years
2023-02-21
DOIhttps://doi.org/10.1186/s12916-023-02763-4
Source Title
Abstract
Castration-resistant prostate cancer often metastasizes to the bone, and such bone metastases eventually become resistant to available therapies, leading to the death of patients. Enriched in the bone, TGF-β plays a pivotal role in bone metastasis development. However, directly targeting TGF-β or its receptors has been challenging for the treatment of bone metastasis. We previously found that TGF-β induces and then depends on the acetylation of transcription factor KLF5 at K369 to regulate multiple biological processes, including the induction of EMT, cellular invasiveness, and bone metastasis. Acetylated KLF5 (Ac-KLF5) and its downstream efectors are thus potential therapeutic targets for treating TGF-β-induced bone metastasis in prostate cancer
Indexed By
Language
English
SUSTech Authorship
First ; 共同第一 ; Corresponding
Data Source
人工提交
Citation statistics
Cited Times [WOS]:0
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/475106
DepartmentDepartment of Human Cell Biology and Genetics
南方科技大学医学院
Affiliation
1.Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology
2.Department of Urology, Kidney and Urology Center, Pelvic Floor Disorders Center, the Seventh Afliated Hospital, Sun Yat-sen University
First Author AffilicationDepartment of Human Cell Biology and Genetics;  School of Medicine
Corresponding Author AffilicationDepartment of Human Cell Biology and Genetics;  School of Medicine
First Author's First AffilicationDepartment of Human Cell Biology and Genetics;  School of Medicine
Recommended Citation
GB/T 7714
Qingqing Huang,Mingcheng Liu,Duo Zhang,et al. Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer[J]. BMC Medicine,2023.
APA
Qingqing Huang.,Mingcheng Liu.,Duo Zhang.,Bing‑Biao Lin.,Xing Fu.,...&Jin‑Tang Dong.(2023).Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.BMC Medicine.
MLA
Qingqing Huang,et al."Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer".BMC Medicine (2023).
Files in This Item:
File Name/Size DocType Version Access License
Nitazoxanide inhibit(4762KB) Open Access--View
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Qingqing Huang]'s Articles
[Mingcheng Liu]'s Articles
[Duo Zhang]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Qingqing Huang]'s Articles
[Mingcheng Liu]'s Articles
[Duo Zhang]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Qingqing Huang]'s Articles
[Mingcheng Liu]'s Articles
[Duo Zhang]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.pdf
Format: Adobe PDF
File name: Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.pdf
Format: Adobe PDF
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.